Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Breast Surgery
  •  Orthopaedic Surgery
  •  Emergency Surgery
  •  Gynecological Surgery
  •  Minimally Invasive Surgery
  •  Robotic Surgery
  •  General Surgery
  •  Endocrine Surgery

Abstract

Citation: Clin Surg. 2016;1(1):1279.Research Article | Open Access

The Predictive Value of the Modified Glasgow Prognostic Score (Mgps) in Determining Outcome Following Elective Colorectal Cancer Surgery

Thomas IM, Amin A, Szczachor J, Rayner S, Wood K and Lim M

Department of General Surgery, Raigmore Hospital, UK

*Correspondance to: Michael Lim 

 PDF  Full Text DOI: 10.25107/2474-1647.1279

Abstract

Background: The mGPS (modified Glasgow Prognostic Score) provides a measure of systemic inflammation in patients with cancer, based on C-reactive protein (CRP) and Albumin. The aim of this study was to determine the role of mGPS in predicting outcome following elective curative colorectal cancer resections; in terms of survival, stage of disease, likelihood and interval of cancer recurrence.Methods: We in Raigmore Hospital, Inverness have a prospective database of patients undergoing colorectal cancer resections. This database was reviewed between January 2008 and January 2012, yielding 986 patients. Data on pre-operative CRP and Albumin, survival, pathology, and recurrence was collected retrospectively, with patients followed up to 1st February 2015. Patients were classified according to their mGPS score. The mGPS was calculated as follows: CRP< 10mg/L=mGPS 0; CRP >10mg/L or Albumin≤ 35g/L=mGPS 1; CRP >10mg/L and Albumin≤ 35g/L=mGPS 2. Data was found to be parametric and comparisons between mGPS groups were done using the ANOVA test. A p-value of < 0.05 was deemed significant.Results: 387 patients were eligible for inclusion (having had elective curative resections with a calculable mGPS). Survival was significantly different at 45.7, 39.9 and 35.9 months for mGPS groups of 0-2 respectively (p=0.0012). Although there was a trend towards higher TNM staging with rising mGPS, this was not significant (p=0.054). Higher mGPS predicted an increased chance of disease recurrence, with a 17.6% vs. 31.6% vs. 37.1% recurrence rate for mGPS groups of 0-2 respectively. Higher mGPS scores were also associated with a significantly shorter time to recurrence, at 42.3 vs. 34.9 vs. 28.9 months (p=0.0008).Conclusion: The mGPS has value in predicting survival, disease recurrence and time to recurrence in colorectal cancer. The score may be helpful as a decision making tool for the multidisciplinary team.

Keywords

Cite the article

Thomas IM, Amin A, Szczachor J, Rayner S, Wood K, Lim M. The Predictive Value of the Modified Glasgow Prognostic Score (Mgps) in Determining Outcome Following Elective Colorectal Cancer Surgery. Clin Surg. 2016; 1: 1279.

Search Our Journal

Journal Indexed In

Articles in PubMed

Mesh Sprayer Device with Liquefied Mesh Delivery System: Proposed Alternative for Currently Available Meshes in Hernia Repair and Supplement to Abdominal Closure
 PubMed  PMC  PDF  Full Text
Automated Sagittal Craniosynostosis Classification from CT Images Using Transfer Learning
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Impact of Roux-en-Y Gastric Bypass on Bone Metabolism in Chinese Obese Patient
 Abstract  PDF  Full Text
Inflammatory Pseudotumor of the Liver Misdiagnosed Malignancy: A Case Report
 Abstract  PDF  Full Text
View More...